How should we treat tophaceous gout in patients with allopurinol hypersensitivity?

被引：0
|
作者：
Grahame, R [1 ]
Simmonds, HA [1 ]
McBride, MB [1 ]
Marsh, FP [1 ]
机构：
[1] Guys Hosp, UMDS, Dept Rheumatol, London SE1 9RT, England
来源：
PURINE AND PYRIMIDINE METABOLISM IN MAN IX | 1998年 / 431卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We studied purine metabolism in gouty patients from three categories: primary gout, familial juvenile hyperuricaemic nephropathy (FJHN) and partial HPRT deficiency.
引用
收藏
页码：19 / 23
页数：5
相关论文
共 50 条
  • [21] AS COMPARED WITH ALLOPURINOL ONLY FEBUXOSTAT PRESERVES VASCULAR FUNCTION IN PATIENTS WITH CHRONIC TOPHACEOUS GOUT
    Tausche, A-K.
    Christoph, M.
    Forkmann, M.
    Richter, U.
    Aringer, M.
    Wunderlich, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 704 - 704
  • [22] Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol
    Richette, Pascal
    Bardin, Thomas
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (06): : 338 - 342
  • [23] How long should we treat?
    Roux, C.
    Briot, K.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (06) : 1659 - 1666
  • [24] How long should we treat?
    C. Roux
    K. Briot
    Osteoporosis International, 2014, 25 : 1659 - 1666
  • [25] How should we treat afibrinogenaemia patients with thrombotic complications
    Brand, B.
    Pfammatter, T.
    Amann-Vesti, B.
    Bachli, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 538 - 538
  • [26] How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?
    Tsimihodimos, Vasilios
    Florentin, Matilda
    Elisaf, Moses S.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (21) : 3773 - 3787
  • [27] How should we best treat patients with bloodstream infections?
    Eduardo Lopez-Cortes, Luis
    de Cueto, Marina
    Rodriguez-Bano, Jesus
    FUTURE MICROBIOLOGY, 2017, 12 (11) : 927 - 930
  • [28] HOW SHOULD WE TREAT ANIMALS
    CHALLINOR, D
    NEW SCIENTIST, 1983, 98 (1354) : 155 - 156
  • [29] HOW LONG SHOULD WE TREAT?
    Roux, Christian
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S53 - S53
  • [30] HOW SHOULD WE TREAT ENVIRONMENT
    HARE, FK
    SCIENCE, 1970, 167 (3917) : 352 - &
12345